The global glycomics market is anticipated to witness a robust growth over the forecast period. This is attributed to factors such as the increasing prevalence of cancer, diabetes, and other chronic disorders, as well as the growing demand for personalized medicines and diagnostics. The growth of the market is due to emerging use of glycans as biomarker, increased prevalence of cancer, advancing technology for glycan analysis, collaborations and partnerships among market players for the development of glycobiology products.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525
Key Benefits for Stakeholders
• The report provides an extensive analysis of the current and emerging market trends and dynamics in the global glycomics market.
• In-depth analysis is conducted by constructing market estimations for the key market segments between 2022 and 2027.
• Extensive analysis of the market is conducted by following key product positioning and monitoring the top competitors within the market framework.
• A comprehensive analysis of all the regions is provided to determine the prevailing opportunities.
• Key market players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
Glycomics is a branch of biochemistry that studies the structure and functions of carbohydrates, or glycans, which are ubiquitous molecules that play crucial roles in various biological processes. Glycomics is a rapidly growing field, driven by the advancement of technologies, such as high-throughput glycan profiling, which enable researchers to characterize the glycome, or the total set of glycans in a biological system.
The rising prevalence of chronic diseases, such as cancer, diabetes, and other metabolic disorders, as well as the growing need for personalized medicines and diagnostics, are expected to drive the growth of the glycomics market. Moreover, the emergence of mass spectrometry and other high-throughput glycan profiling technologies is further anticipated to enhance the market growth.
The growing focus on the development of vaccines, diagnostics, and therapeutics against various infectious diseases is also expected to drive the growth of the glycomics market. Additionally, the increasing use of glycomics in drug discovery, food safety, and quality control is likely to boost the market growth.
However, the high cost of glycomics technologies and the lack of skilled professionals are expected to restrain the growth of the glycomics market. Furthermore, the lack of awareness about glycomics among healthcare professionals is expected to hamper the market growth.
Key Market Players:
The global glycomics/glycobiology market is highly competitive. The prominent players operating in this market include Thermo Fisher Scientific (US), New England Biolabs (US), Merck KGaA (Germany), Promega Corporation (US), Waters Corporation (US), Takara Bio Inc, (Japan), Bio-Techne (US), Agilent Technologies (US), Sumitomo Bakelite Co. Ltd. (Japan), Bruker Corporation (US), Shimadzu Corporation (Japan), Danaher Corporation (US), AMS Bio (UK), Ludger Ltd (UK), Z Biotech, LLC (US), Chemily Glycoscience (US), CD BioGlyco (US), GlycoDiag (France), Kode Biotech Limited (New Zealand), Glyxera GmBH (Germany), Lectenz Bio (US), Glycomix Ltd (UK), IEC Group (Italy), Asparia Glycomics (Spain) and Ray Biotech Life Inc. (US) . Product launch, partnerships, collaborations and geographic expansion are the key growth strategies undertaken by these companies to maintain their positions in the market
Merck KGaA is also one of the leading players in the glycomics/glycobiology market. The company focuses on inorganic growth strategies such as investment to strengthen its market position. The company invested USD 20.52 Million to build new science laboratory in Switzerland for fostering the experiments and research.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525
This report categorizes the glycomics/ glycobiology market into the following segments and subsegments
Glycomics/ Glycobiology Market, By Product
• Enzymes
• Instruments
• Kits
• Carbohydrates
• Reagents & Chemicals
Glycomics/ Glycobiology Market, By Application
• Drug Discovery & Development
• Diagnostics
• Cancer Diagnostics
• Other Diagnostics
• Other Applications
Glycomics/ Glycobiology Market, By End User
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Clinical Laboratories
• Contract Research Organizations (CROs)
Glycomics/ Glycobiology Market, By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
Recent Developments
• Bruker Corporation (US) acquired the IonSense (US) for expansion of the use of DART Mass spectrometers.
• GlycoNet (Canada) and BridgeBio Pharma Inc, (US) entered into partnership for developing medicines for treating genetic diseases through glycobiology research.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=13...
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]